BACKGROUND: Although a high number of patients with congenital heart disease (CHD) undergo surgical palliation or definite correction up to adolescence, adult congenital heart disease (ACHD) may remain a potential lifelong risk factor for infective endocarditis (IE) in patients growing up with congenital heart disease (GUCH). METHODS: In a retrospective case study of a tertiary care center long-term clinical course and complications of patients with IE and GUCH were analysed. RESULTS: Data of 52 patients with CHD, who fulfilled the Saiman criteria for infective endocarditis and were treated between April 1986 and March 2001, were identified: Risk factors for infective endocarditis were previous cardiovascular operation (51.9%), use of foreign material (38.5%), dental or other surgical procedures without recommended antibiotic prophylaxis (25.0%), or cardiac catheterization (5.8%). Staphylococcal (38.9%) or streptococcal species (35.2%) were cultivated in most cases as causative microorganisms. Complications were: recurrence of IE (7.7%), septic embolisms (30.8%) leading to central nervous complications (7.7%), embolism of pulmonary arteries (7.7%), renal arteries (1.9%), arteries of the extremities (9.6%), or infarction of spleen (1.9%). Other cardiac (23.1%) or extracardiac (13.5%) complications were frequent. The need of re-operations during or after IE was high (67.3%). The hospital mortality was 1.9%, late mortality was 7.7%. CONCLUSIONS: Patients with IE and CHD show a broad clinical spectrum of cardiac and extracardiac complications. They may lead to a complicative short- and long-term course with the potential risk of death and a high number of re-operation. Efforts have to be made to improve long-term outcome of patients with ACHD by an interdisciplinary cooperation.
BACKGROUND: Although a high number of patients with congenital heart disease (CHD) undergo surgical palliation or definite correction up to adolescence, adult congenital heart disease (ACHD) may remain a potential lifelong risk factor for infective endocarditis (IE) in patients growing up with congenital heart disease (GUCH). METHODS: In a retrospective case study of a tertiary care center long-term clinical course and complications of patients with IE and GUCH were analysed. RESULTS: Data of 52 patients with CHD, who fulfilled the Saiman criteria for infective endocarditis and were treated between April 1986 and March 2001, were identified: Risk factors for infective endocarditis were previous cardiovascular operation (51.9%), use of foreign material (38.5%), dental or other surgical procedures without recommended antibiotic prophylaxis (25.0%), or cardiac catheterization (5.8%). Staphylococcal (38.9%) or streptococcal species (35.2%) were cultivated in most cases as causative microorganisms. Complications were: recurrence of IE (7.7%), septic embolisms (30.8%) leading to central nervous complications (7.7%), embolism of pulmonary arteries (7.7%), renal arteries (1.9%), arteries of the extremities (9.6%), or infarction of spleen (1.9%). Other cardiac (23.1%) or extracardiac (13.5%) complications were frequent. The need of re-operations during or after IE was high (67.3%). The hospital mortality was 1.9%, late mortality was 7.7%. CONCLUSIONS:Patients with IE and CHD show a broad clinical spectrum of cardiac and extracardiac complications. They may lead to a complicative short- and long-term course with the potential risk of death and a high number of re-operation. Efforts have to be made to improve long-term outcome of patients with ACHD by an interdisciplinary cooperation.
Authors: Candice K Silversides; Ariane Marelli; Luc Beauchesne; Annie Dore; Marla Kiess; Omid Salehian; Timothy Bradley; Jack Colman; Michael Connelly; Louise Harris; Paul Khairy; Seema Mital; Koichiro Niwa; Erwin Oechslin; Nancy Poirier; Markus Schwerzmann; Dylan Taylor; Isabelle Vonder Muhll; Helmut Baumgartner; Lee Benson; David Celermajer; Matthias Greutmann; Eric Horlick; Mike Landzberg; Folkert Meijboom; Barbara Mulder; Carole Warnes; Gary Webb; Judith Therrien Journal: Can J Cardiol Date: 2010-03 Impact factor: 5.223
Authors: Steffen Koerdt; Julia Hartz; Stefan Hollatz; Gesche Frohwitter; Marco R Kesting; Peter Ewert; Renate Oberhoffer; Herbert Deppe Journal: Clin Oral Investig Date: 2017-10-16 Impact factor: 3.573
Authors: J Fortún; T Centella; P Martín-Dávila; M J Lamas; C Pérez-Caballero; L Fernández-Pineda; E Otheo; J Cobo; E Navas; V Pintado; E Loza; S Moreno Journal: Infection Date: 2012-09-07 Impact factor: 3.553
Authors: Myo Thidar Lwin; Victor Tsoi; Tat Yam; Aisling Carroll; Tony Salmon; Stephen Harden; Lindsay Smith Journal: Eur Heart J Case Rep Date: 2021-03-31